{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T16:14:46Z","timestamp":1777133686613,"version":"3.51.4"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Regulation of the serum calcium level in humans is achieved by the endocrine action of parathyroid glands working in concert with vitamin D and a set of critical target cells and tissues including osteoblasts, osteoclasts, the renal tubules, and the small intestine. The parathyroid glands, small highly vascularized endocrine organs located behind the thyroid gland, secrete parathyroid hormone (PTH) into the systemic circulation as is needed to keep the serum free calcium concentration within a tight physiologic range. Primary hyperparathyroidism (HPT), a disorder of mineral metabolism usually associated with abnormally elevated serum calcium, results from the uncontrolled release of PTH from one or several abnormal parathyroid glands. Although in the vast majority of cases HPT is a sporadic disease, it can also present as a manifestation of a familial syndrome. Many benign and malignant sporadic parathyroid neoplasms are caused by loss-of-function mutations in tumor suppressor genes that were initially identified by the study of genomic DNA from patients who developed HPT as a manifestation of an inherited syndrome. Somatic and inherited mutations in certain proto-oncogenes can also result in the development of parathyroid tumors. The clinical and genetic investigation of familial HPT in kindreds found to lack germline variants in the already known HPT-predisposition genes represents a promising future direction for the discovery of novel genes relevant to parathyroid tumor development.<\/jats:p>","DOI":"10.3389\/fendo.2021.623667","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T09:13:06Z","timestamp":1614244386000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Familial Hyperparathyroidism"],"prefix":"10.3389","volume":"12","author":[{"given":"Jenny E.","family":"Blau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Simonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary Hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2174\/138945007779315614","article-title":"Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors","volume":"8","author":"Brauner-Osborne","year":"2007","journal-title":"Curr Drug Targets"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R116.735894","article-title":"Why Calcium? How Calcium Became the Best Communicator","volume":"291","author":"Carafoli","year":"2016","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2013.02.006","article-title":"Role of the calcium-sensing receptor in extracellular calcium homeostasis","volume":"27","author":"Brown","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00441","article-title":"Molecular Basis of the Extracellular Ligands Mediated Signaling by the Calcium Sensing Receptor","volume":"7","author":"Zhang","year":"2016","journal-title":"Front Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-5-2114","article-title":"1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture","volume":"117","author":"Cantley","year":"1985","journal-title":"Endocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/endo-119-6-2864","article-title":"Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene","volume":"119","author":"Russell","year":"1986","journal-title":"Endocrinology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40610-019-0118-1","article-title":"Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders","volume":"5","author":"Weber","year":"2019","journal-title":"Curr Mol Biol Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00424-018-2231-z","article-title":"Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi)","volume":"471","author":"Jacquillet","year":"2019","journal-title":"Pflugers Arch"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.17","article-title":"Recent advances in renal phosphate handling","volume":"6","author":"Farrow","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09614-0","article-title":"Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism","author":"Silva","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.10.013","article-title":"Parathyroid cancer","volume":"37","author":"Sharretts","year":"2010","journal-title":"Semin Oncol"},{"key":"B16","article-title":"Parathyroid Cancer","volume-title":"StatPearls","author":"Byrd","year":"2020"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary Hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1610","article-title":"Molecular genetics of multiple endocrine neoplasia types 1 and 2","volume":"5","author":"Marx","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B19","volume-title":"CDC73-Related Disorders","author":"Hyde","year":""},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: Clinical and genetic characteristics of thirty-six kindreds","volume":"81","author":"Simonds","year":"2002","journal-title":"Med (Baltimore)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00005792-198111000-00002","article-title":"The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds","volume":"60","author":"Marx","year":"1981","journal-title":"Med (Baltimore)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/323643a0","article-title":"A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma","volume":"323","author":"Friend","year":"1986","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.9257","article-title":"American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers","volume":"32","author":"Lu","year":"2014","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.41","article-title":"The molecular pathology of cancer","volume":"7","author":"Harris","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"B27","first-page":"131","article-title":"Studies in acromegaly V. The pathological finding in four autopsied cases of acromegaly with a discussion of their significance (Monographs of the Rockefeller Institute for Medical Research)","author":"Cushing","year":"1927"},{"key":"B28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/jcem-13-1-20","article-title":"Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved","volume":"13","author":"Underdahl","year":"1953","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00000441-195408000-00008","article-title":"Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumor of the pituitary: a syndrome with a familial incidence","volume":"228","author":"Moldawer","year":"1954","journal-title":"Am J Med Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-195510000-00015","article-title":"Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas","volume":"142","author":"Zollinger","year":"1955","journal-title":"Ann Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/332085a0","article-title":"Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma","volume":"332","author":"Larsson","year":"1988","journal-title":"Nature"},{"key":"B33","article-title":"Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1","volume":"51","author":"Bale","year":"1991","journal-title":"Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.4.1630","article-title":"Menin, the product of the MEN1 gene, is a nuclear protein","volume":"95","author":"Guru","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0199","article-title":"The future: genetics advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Agarwal","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1385","article-title":"Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours","volume":"83","author":"Bergman","year":"2000","journal-title":"Br J Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2017.69.3.181","article-title":"Neuroendocrine Tumors in the Stomach, Duodenum, and Pancreas Accompanied by Novel MEN1 Gene Mutation","volume":"69","author":"Yang","year":"2017","journal-title":"Korean J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/po.17.00267","article-title":"Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability","volume":"2018","author":"Raj","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.21.5988","article-title":"Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1038\/s41467-018-06498-2","article-title":"ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup","volume":"9","author":"Chan","year":"2018","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/jme-20-0020","article-title":"c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs","volume":"65","author":"Lee","year":"2020","journal-title":"J Mol Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0564","article-title":"Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors","volume":"94","author":"Newey","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1322-5","article-title":"MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors","volume":"59","author":"Vannucci","year":"2018","journal-title":"Endocrine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"25","author":"Louren\u00e7o","year":"2010","journal-title":"J Bone Miner Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb00938.x","article-title":"Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1","volume":"35","author":"Marx","year":"1991","journal-title":"Clin Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4161\/epi.24823","article-title":"Global and gene-specific promoter methylation analysis in primary hyperparathyroidism","volume":"8","author":"Sulaiman","year":"2013","journal-title":"Epigenetics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.05.010","article-title":"Alterations of DNA methylation in parathyroid tumors","volume":"469","author":"Guarnieri","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603023","article-title":"MicroRNAs in cell proliferation, cell death, and tumorigenesis","volume":"94","author":"Hwang","year":"2006","journal-title":"Br J Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.608975","article-title":"The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells","volume":"10","author":"Ghafouri-Fard","year":"2020","journal-title":"Front Oncol"},{"key":"B54","article-title":"Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas","volume":"9","author":"Luzi","year":"2017","journal-title":"Am J Transl Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.05.005","article-title":"Update on the Genetics of Pituitary Tumors","volume":"49","author":"Barry","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199608000-00008","article-title":"Results of treatment of pituitary disease in multiple endocrine neoplasia, type I","volume":"39","author":"O\u2019Brien","year":"1996","journal-title":"Neurosurgery"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(sup01)09","article-title":"Pituitary tumors in patients with MEN1 syndrome","author":"Syro","year":"2012","journal-title":"Clinics (Sao Paulo Brazil)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031511","article-title":"Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma","volume":"89","author":"Hao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2015","article-title":"Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0450-3","article-title":"Hereditary neuroendocrine tumors of the gastroenteropancreatic system","volume":"451","author":"Anlauf","year":"2007","journal-title":"Virchows Arch"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/s2213-8587(15)00043-1","article-title":"Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1","volume":"3","author":"Yates","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.3","article-title":"Current and emerging therapies for PNETs in patients with or without MEN1","volume":"14","author":"Frost","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/jme-18-0050","article-title":"Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types","volume":"61","author":"Iyer","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1159\/000511791","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1) and the Pancreas - Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement","author":"Niederle","year":"2020","journal-title":"Neuroendocrinology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","article-title":"Multiple Endocrine Neoplasia Type 2","volume-title":"GeneReviews [Internet]","author":"Eng","year":"1999"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2742","article-title":"Targeting the RET pathway in thyroid cancer","volume":"15","author":"Wells","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22542-5_6","article-title":"Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation","volume":"204","author":"Frank-Raue","year":"2015","journal-title":"Recent Results Cancer Res"},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1016\/S0039-6060(98)70093-5","article-title":"Multiple endocrine neoplasia type 2-associated RET proto-oncogene mutations do not contribute to the pathogenesis of sporadic parathyroid tumors","volume":"124","author":"Willeke","year":"1998","journal-title":"Surgery"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.7.8675600","article-title":"Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2","volume":"81","author":"Pausova","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B76","article-title":"Recessive transmission of a multiple endocrine neoplasia syndrome in the rat","volume":"62","author":"Fritz","year":"2002","journal-title":"Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(sup01)04","article-title":"MENX and MEN4","volume":"67","author":"Pellegata","year":"2012","journal-title":"Clinics (Sao Paulo Brazil)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21354","article-title":"A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04269.x","article-title":"Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain","volume":"76","author":"Belar","year":"2012","journal-title":"Clin Endocrinol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0929","article-title":"Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003350","article-title":"A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PloS Genet"},{"key":"B84","doi-asserted-by":"publisher","first-page":"K7","DOI":"10.1530\/EJE-14-0080","article-title":"A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/510985","article-title":"Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B","volume":"2015","author":"Elston","year":"2015","journal-title":"Case Rep Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mce.2013.09.005","article-title":"Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors","volume":"386","author":"Costa-Guda","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","article-title":"Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing\u2019s Disease With or Without an MEN4 Phenotype","volume":"105","author":"Chasseloup","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B90","article-title":"Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome","volume":"108","author":"Jackson","year":"1990","journal-title":"Surgery"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-49-4-829","article-title":"Hereditary hyperparathyroidism associated with recurrent pancreatitis","volume":"49","author":"Jackson","year":"1958","journal-title":"Ann Intern Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19921215)70:12<2988::aid-cncr2820701242>3.0.co;2-v","article-title":"The WHO Histological Typing of Odontogenic Tumours. A commentary on the Second Edition","volume":"70","author":"Kramer","year":"1992","journal-title":"Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4103\/0976-237X.94553","article-title":"Cemento-ossifying fibroma","volume":"3","author":"Ram","year":"2012","journal-title":"Contemp Clin Dent"},{"key":"B94","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1259\/dmfr\/96330046","article-title":"Ossifying fibromas of the jaw bone: 20 cases","volume":"39","author":"Liu","year":"2010","journal-title":"Dentomaxillofac Radiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","article-title":"Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome","volume":"257","author":"Bradley","year":"2005","journal-title":"J Intern Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01168.x","article-title":"Hyperparathyroidism-jaw tumour syndrome","volume":"253","author":"Chen","year":"2003","journal-title":"J Intern Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1761030","article-title":"Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature","volume":"2019","author":"Torresan","year":"2019","journal-title":"Int J Endocrinol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2014.08.004","article-title":"Hyperparathyroidism-jaw tumor syndrome: Results of operative management","volume":"156","author":"Mehta","year":"2014","journal-title":"Surgery"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-20-0149","article-title":"Genotype of CDC73 germline mutation determines risk of parathyroid cancer","volume":"27","author":"Li","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","article-title":"Parafibromin\u2013functional insights","volume":"266","author":"Newey","year":"2009","journal-title":"J Intern Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04184.x","article-title":"Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism","volume":"76","author":"Domingues","year":"2012","journal-title":"Clin Endocrinol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20911","article-title":"Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family","volume":"50","author":"Cascon","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12881-017-0445-0","article-title":"Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family","volume":"18","author":"Guarnieri","year":"2017","journal-title":"BMC Med Genet"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.12.8954016","article-title":"Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas","volume":"81","author":"Teh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.11.013","article-title":"CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors","volume":"124","author":"Vocke","year":"2019","journal-title":"Urology"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(98)80038-1","article-title":"Benign mixed epithelial and stromal tumor of the kidney","volume":"194","author":"Michal","year":"1998","journal-title":"Pathol Res Pract"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-004-1060-y","article-title":"Mixed epithelial and stromal tumors of the kidney. A report of 22 cases","volume":"445","author":"Michal","year":"2004","journal-title":"Virchows Arch"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.33.123","article-title":"Familial primary hyperparathyroidism complicated with Wilms\u2019 tumor","volume":"33","author":"Kakinuma","year":"1994","journal-title":"Intern Med"},{"key":"B116","article-title":"Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31","volume":"56","author":"Szabo","year":"1995","journal-title":"Am J Hum Genet"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02789","article-title":"New Concepts About Familial Isolated Hyperparathyroidism","volume":"104","author":"Marx","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B119","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1210\/jc.2003-030675","article-title":"Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome","volume":"89","author":"Simonds","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.016725","article-title":"Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications","volume":"41","author":"Warner","year":"2004","journal-title":"J Med Genet"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02438.x","article-title":"Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management","volume":"64","author":"Cetani","year":"2006","journal-title":"Clin Endocrinol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346498","article-title":"Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition","volume":"32","author":"Vierimaa","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-013-0551-9","article-title":"Genetic basis of familial isolated hyperparathyroidism: a case series and a narrative review of the literature","volume":"32","author":"Pontikides","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.026898","article-title":"Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism","volume":"42","author":"Baumber","year":"2005","journal-title":"J Med Genet"},{"key":"B125","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/humu.20827","article-title":"Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism","volume":"30","author":"Canaff","year":"2009","journal-title":"Hum Mutat"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00043","article-title":"Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism","volume":"1","author":"Guan","year":"2017","journal-title":"J Endocr Soc"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01107-5","article-title":"Whole exome sequencing in familial isolated primary hyperparathyroidism","volume":"43","author":"Cetani","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02517","article-title":"Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas","volume":"104","author":"Riccardi","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.2800","article-title":"Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia","volume":"8","author":"Papadopoulou","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(05)70148-1","article-title":"Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium","volume":"29","author":"Brown","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14254","article-title":"Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort","volume":"93","author":"Mariathasan","year":"2020","journal-title":"Clin Endocrinol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000185516","article-title":"Mutations in the calcium-sensing receptor and their clinical implications","volume":"48","author":"Brown","year":"1997","journal-title":"Horm Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2516","article-title":"Polyclonality of Parathyroid Tumors in Neonatal Severe Hyperparathyroidism","volume":"30","author":"Corrado","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.10.4300","article-title":"Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism","volume":"82","author":"Farnebo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.11.7593409","article-title":"Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors","volume":"80","author":"Hosokawa","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.6.878","article-title":"No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas","volume":"14","author":"Cetani","year":"1999","journal-title":"J Bone Miner Res"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2778","article-title":"A G-protein Subunit-alpha11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2)","volume":"31","author":"Gorvin","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jbmr.3241","article-title":"Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Galpha11 Mutation","volume":"33","author":"Gorvin","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1120","article-title":"Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations","volume":"99","author":"Hendy","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3442","article-title":"Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy010","article-title":"Large-scale exome datasets reveal a new class of adaptor-related protein complex 2 sigma subunit (AP2sigma) mutations, located at the interface with the AP2 alpha subunit, that impair calcium-sensing receptor signalling","volume":"27","author":"Gorvin","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.5.4806","article-title":"Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas","volume":"83","author":"Palanisamy","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-4608(98)00049-1","article-title":"Comparative genomic hybridization analysis of human parathyroid tumors","volume":"106","author":"Agarwal","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.10.6057","article-title":"Alternative genetic pathways in parathyroid tumorigenesis","volume":"84","author":"Farnebo","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64568-3","article-title":"Patterns of chromosomal imbalances in parathyroid carcinomas","volume":"157","author":"Kytola","year":"2000","journal-title":"Am J Pathol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460209","article-title":"Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas","volume":"146","author":"Garcia","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0388-5","article-title":"Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age","volume":"34","author":"Skandarajah","year":"2010","journal-title":"World J Surg"},{"key":"B153","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","article-title":"Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism","volume":"3","author":"Starker","year":"2012","journal-title":"Horm Cancer"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.623667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T09:13:15Z","timestamp":1614244395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.623667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":153,"alternative-id":["10.3389\/fendo.2021.623667"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.623667","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"article-number":"623667"}}